You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
迪安診斷(300244.SZ)第三季度淨利潤預增20%-35%
格隆匯 10-15 16:50

格隆匯10月15日丨迪安診斷(300244.SZ)公佈,預計2021年前三季度歸屬於上市公司股東的淨利潤11.69億元–13.04億元,同比增長30%-45%;其中,第三季度歸屬於上市公司股東的淨利潤4.78億元–5.37億元,同比增長20%-35%。業績變動原因如下:

 1報吿期內,公司堅定按照5年戰略規劃及年度經營計劃的部署,通過技術創新和模式創新交替升級,不斷強化具有綜合壁壘的多疾病一體化服務產業鏈。持續加強學科建設、技術平台搭建、新項目開展和臨牀增值服務,全面推進價值醫療趨勢下的以疾病為中心的整體化解決方案;發揮競爭優勢抓住醫改機遇,深度推進在醫聯體/醫共體政策下的區域中心的合作共建;嫁接全國佈局的自有銷售和終端客户網絡,穩步推進精準診療需求下的高精尖產品研發、生產和市場推廣;增強服務技術輸出和優化產品結構,速推進集採及國產替代潮下的供應鏈變革和大服務融合;全盤聯動全力以赴,高效推進後疫情時代的常態臨牀檢驗局部區域的抗疫防疫攻堅。報吿期內,公司繼續精益管理,優化運營效率,營業收入和淨利潤持續呈現健康穩定增長態勢。

2 預計2021年前三季度非經常性損益對公司淨利潤的影響金額約6000-7000萬元。

3預計2021年前三季度股權激勵費用對公司淨利的影響金額6000萬元

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account